Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, United States.
Thermo Fisher Scientific, Rockford, Illinois 61101, United States.
J Proteome Res. 2024 Nov 1;23(11):5153-5165. doi: 10.1021/acs.jproteome.4c00668. Epub 2024 Oct 9.
Mass spectrometry-based sample multiplexing with isobaric tags permits the development of high-throughput and precise quantitative biological assays with proteome-wide coverage and minimal missing values. Here, we nearly doubled the multiplexing capability of the TMTpro reagent set to a 35-plex through the incorporation of one deuterium isotope into the reporter group. Substituting deuterium frequently results in suboptimal peak coelution, which can compromise the accuracy of reporter ion-based quantification. To counteract the deuterium effect on quantitation, we implemented a strategy that necessitated the segregation of nondeuterium and deuterium-containing channels into distinct subplexes during normalization procedures, with reassembly through a common bridge channel. This multiplexing strategy of "design independent sub-plexes but acquire together" (DISAT) was used to compare protein expression differences between human cell lines and in a cysteine-profiling (i.e., chemoproteomics) experiment to identify compounds binding to cysteine-113 of Pin1.
基于质谱的同量异位标签样品多路复用技术可实现高通量和精确的定量生物学分析,具有蛋白质组全覆盖和最小缺失值。在这里,我们通过在报告基团中引入一个氘同位素,将 TMTpro 试剂的多路复用能力提高到了 35 重。频繁取代氘通常会导致峰洗脱不理想,从而影响基于报告离子定量的准确性。为了抵消氘对定量的影响,我们实施了一种策略,即在归一化过程中需要将非氘和氘含量的通道分离到不同的亚通道中,并通过一个共同的桥通道重新组装。这种“独立设计亚通道但一起采集”(DISAT)的多路复用策略用于比较人细胞系之间的蛋白质表达差异,以及在半胱氨酸分析(即化学蛋白质组学)实验中,以鉴定与 Pin1 的半胱氨酸 113 结合的化合物。